Explore more publications!
Missouri Health Digest
Got News to Share?

Missouri Health Digest: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Missouri Health Digest.

February 2026

Mo Tu We Th Fr Sa Su
1
2 3 4 5 6 7 8
9 10 11 12 13 14 15
16 17 18 19 20 21 22
23 24 25 26 27 28

March 2026

Mo Tu We Th Fr Sa Su
1
2 3 4 5 6 7 8
9 10 11 12 13 14 15
16 17 18 19 20 21 22
23 24 25 26 27 28 29
30 31

April 2026

Mo Tu We Th Fr Sa Su
1 2 3 4 5
6 7 8 9 10 11 12
13 14 15 16 17 18 19
20 21 22 23 24 25 26
27 28 29 30

Press releases published on March 6, 2026

Tris Pharma Announces Positive Debut Data from Phase 3 ALLEVIATE-1 and 2 Trials Evaluating Cebranopadol in Acute Pain at AAPM PainConnect 2026 Annual Meeting
Mar. 6, 2026

Tris Pharma Announces Positive Debut Data from Phase 3 ALLEVIATE-1 and 2 Trials Evaluating Cebranopadol in Acute Pain at AAPM PainConnect 2026 Annual Meeting

Indeterminate GlobeNewswire
An International Women’s Day weekend event promises to teach us about the depth and breadth of women’s health
Mar. 6, 2026

An International Women’s Day weekend event promises to teach us about the depth and breadth of women’s health

Indeterminate GlobeNewswire
CardioGLYX Blood Balance Support Claims Evaluated: 2026 Consumer Report Examines Blood Sugar, Cholesterol and Metabolic Ingredient Research
Mar. 6, 2026

CardioGLYX Blood Balance Support Claims Evaluated: 2026 Consumer Report Examines Blood Sugar, Cholesterol and Metabolic Ingredient Research

Indeterminate GlobeNewswire
Nika Pharmaceuticals, Inc. (NIKA) Signed a Consultancy Agreement with MD Global Partners LLC
Mar. 6, 2026

Nika Pharmaceuticals, Inc. (NIKA) Signed a Consultancy Agreement with MD Global Partners LLC

Indeterminate GlobeNewswire
SleepZee Anti-Snoring Mouthpiece Consumer Report: 2026 Analysis of Mandibular Advancement Device Research, Snoring Reduction Claims, and What Buyers Should Verify
Mar. 6, 2026

SleepZee Anti-Snoring Mouthpiece Consumer Report: 2026 Analysis of Mandibular Advancement Device Research, Snoring Reduction Claims, and What Buyers Should Verify

Indeterminate GlobeNewswire
Holland Bloorview Kids Rehabilitation Hospital launches its 10th annual Capes for Kids fundraiser
Mar. 6, 2026

Holland Bloorview Kids Rehabilitation Hospital launches its 10th annual Capes for Kids fundraiser

Indeterminate GlobeNewswire
BBOT Announces Publication in Cancer Discovery Highlighting Preclinical Data Demonstrating BBO-11818 is a Potent and Selective panKRAS Inhibitor
Mar. 6, 2026

BBOT Announces Publication in Cancer Discovery Highlighting Preclinical Data Demonstrating BBO-11818 is a Potent and Selective panKRAS Inhibitor

Indeterminate GlobeNewswire
Transforming Healthcare Ltd Founder Dr. Pietro Emanuele Garbelli Wins BREW Readers' Book of the Month for 'The Doctor's Future'
Mar. 6, 2026

Transforming Healthcare Ltd Founder Dr. Pietro Emanuele Garbelli Wins BREW Readers' Book of the Month for 'The Doctor's Future'

Indeterminate GlobeNewswire
Progyny, Inc. Executives to Participate in Upcoming Investor Conferences
Mar. 6, 2026

Progyny, Inc. Executives to Participate in Upcoming Investor Conferences

Indeterminate GlobeNewswire
Standard Dental Labs Inc.: Investor Education Series — Part 3
Mar. 6, 2026

Standard Dental Labs Inc.: Investor Education Series — Part 3

Indeterminate GlobeNewswire
Aethlon Medical to Present at the Life Sciences Investor Forum on March 12th
Mar. 6, 2026

Aethlon Medical to Present at the Life Sciences Investor Forum on March 12th

Indeterminate GlobeNewswire
Solid Biosciences Announces Oversubscribed $240 Million Private Placement
Mar. 6, 2026

Solid Biosciences Announces Oversubscribed $240 Million Private Placement

Indeterminate GlobeNewswire
Calidi Biotherapeutics Announces Pricing of $5.2 Million Underwritten Public Offering
Mar. 6, 2026

Calidi Biotherapeutics Announces Pricing of $5.2 Million Underwritten Public Offering

Indeterminate GlobeNewswire
Servier and Day One Biopharmaceuticals announce acquisition to expand Servier’s rare oncology portfolio
Mar. 6, 2026

Servier and Day One Biopharmaceuticals announce acquisition to expand Servier’s rare oncology portfolio

Indeterminate GlobeNewswire
Solid Biosciences to Present at the 2026 Muscular Dystrophy Association (MDA) Clinical & Scientific Conference
Mar. 6, 2026

Solid Biosciences to Present at the 2026 Muscular Dystrophy Association (MDA) Clinical & Scientific Conference

Indeterminate GlobeNewswire
Allarity Therapeutics Closes $20 Million Financing to Accelerate the Advance of Stenoparib Toward FDA Approval and Commercialization
Mar. 6, 2026

Allarity Therapeutics Closes $20 Million Financing to Accelerate the Advance of Stenoparib Toward FDA Approval and Commercialization

Indeterminate GlobeNewswire
Pacira BioSciences Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Mar. 6, 2026

Pacira BioSciences Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

Indeterminate GlobeNewswire
Taysha Gene Therapies Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
Mar. 6, 2026

Taysha Gene Therapies Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)

Indeterminate GlobeNewswire
Adial Pharmaceuticals Reports 2025 Fiscal Year Financial Results and Provides Business Update
Mar. 6, 2026

Adial Pharmaceuticals Reports 2025 Fiscal Year Financial Results and Provides Business Update

Indeterminate GlobeNewswire
PMV Pharmaceuticals Reports Full Year 2025 Financial Results and Corporate Highlights
Mar. 6, 2026

PMV Pharmaceuticals Reports Full Year 2025 Financial Results and Corporate Highlights

Indeterminate GlobeNewswire
Show More

Share us

on your social networks:
Facebook Facebook LinkedIn LinkedIn
AGPs

Get the latest news on this topic.

SIGN UP FOR FREE TODAY

No Thanks

By signing to this email alert, you
agree to our Terms & Conditions